News & Blog

New Treatment Arms Opening for Patients in NBTS-Funded GBM AGILE Clinical Trial

Yesterday, it was announced that the GBM AGILE adaptive clinical trial platform is opening two new treatment arms, with one evaluating Kintara Therapeutics’s chemotherapy, VAL-083, and Kazia Therapeutics’s targeted therapy, paxalisib.  “NBTS has long supported GBM AGILE as a scientifically cutting-edge and more patient-friendly way to develop and evaluate emerging new treatments for patients,” says […]

Sights & Sounds: Glioblastoma Awareness Day (#GBMDay) 2020

Perhaps Dr. Ned Sharpless, Director of the National Cancer Institute, summed up Glioblastoma (GBM) Awareness Day 2020 best when he said during NBTS’s Defeating GBM: A Virtual Town Hall event, “Events like this are really important to re-energize the community so we can join together and make progress in a disease that where progress has been […]

The Rights of Brain Tumor Patients That Every Country Should Strive to Deliver

On July 3, 2020, the National Brain Tumor Society (NBTS), along with more than 70 of our colleague organizations from across the international brain tumor community, welcomed the release of a new Brain Tumour Patients’ Charter of Rights. The document represents the perspective of brain tumor patients and caregivers and provides a set of standards […]

Share